Cargando…
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
The tumor-permissive and immunosuppressive characteristics of tumor-associated macrophages (TAM) have fueled interest in therapeutically targeting these cells. In this context, the colony-stimulating factor 1 (CSF1)/colony-stimulating factor 1 receptor (CSF1R) axis has gained the most attention, and...
Autores principales: | Cannarile, Michael A., Weisser, Martin, Jacob, Wolfgang, Jegg, Anna-Maria, Ries, Carola H., Rüttinger, Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514481/ https://www.ncbi.nlm.nih.gov/pubmed/28716061 http://dx.doi.org/10.1186/s40425-017-0257-y |
Ejemplares similares
-
Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients
por: Machiels, Jean-Pascal, et al.
Publicado: (2020) -
PK/PD Mediated Dose Optimization of Emactuzumab, a CSF1R Inhibitor, in Patients With Advanced Solid Tumors and Diffuse‐Type Tenosynovial Giant Cell Tumor
por: Smart, Kevin, et al.
Publicado: (2020) -
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
por: Gomez-Roca, Carlos, et al.
Publicado: (2022) -
Cloning and expression of porcine Colony Stimulating Factor-1 (CSF-1) and Colony Stimulating Factor-1 Receptor (CSF-1R) and analysis of the species specificity of stimulation by CSF-1 and Interleukin 34
por: Gow, Deborah J., et al.
Publicado: (2012) -
Cloning and expression of feline colony stimulating factor receptor (CSF-1R) and analysis of the species specificity of stimulation by colony stimulating factor-1 (CSF-1) and interleukin-34 (IL-34)
por: Gow, Deborah J., et al.
Publicado: (2013)